entertainment -WSS

entertainment

author：comprehensive 2025-09-06 04:36:38 - browse：97647

Eli Lilly headquarters — Kristoffer Tripplaar/AP

SAN DIEGO – An experimental pill from Eli Lilly led to 14.7% weight loss on the highest dose in a 36-week trial, heating up the growing competition among drugmakers to develop an effective oral obesity therapy.

The mid-stage results for orforglipron match the estimates of 14-15% weight loss that Lilly gave in an investor call late last year. The full results, published Friday in the New England Journal of Medicine, were presented here to a packed conference room at the American Diabetes Association conference.

By the end of trial, the authors said, participants’ weight loss had not plateaued, suggesting potential for even greater weight loss over a longer treatment period.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： At least 13 dead in Texas as scorching temps continue
Next article： Juul documents reveal insider tactics on political lobbying

WSS

Readout Newsletter: Replicate, Biogen's Leqembi, and Humira

ACIP vaccine advisory panel sees its vacancies filled

Lilly to acquire Dermira for $1.1 billion, adding eczema drug to its pipeline

Tome Biosciences co

Manchin plays down potential 3rd

Robert Kennedy Jr.'s presidential campaign attracts GOP

knowledge

entertainment

hotspot

What does generative AI mean for health care? We asked experts

Biden administration sends mixed signals on US soldier who crossed into North Korea

Malaria cases in Florida and Texas: Here’s what you need to know

Latigo launches with $135 million for Vertex

Heart attack and stroke risk calculators need revising

UK homeowners get some respite as inflation falls by more than anticipated to a 15

At least 13 dead in Texas as scorching temps continue

ACIP vaccine advisory panel sees its vacancies filled

Continuity nursing helped my family in our darkest PICU moments

A look at other Americans who have crossed into North Korea over the years

focus

Resistance to opioid

Britain’s MI6 chief says his spies are using AI to disrupt flow of weapons to Russia

Having children helps parents live longer, especially after age 80

What we know about the American soldier detained in North Korea

House passes resolution saying Israel isn't a 'racist or apartheid state'

Lack of darker skin in textbooks, journals harms patients of color

hotspot

explore

entertainment

leisure time